S. Fred Brunk
Impact in
- Pharmacology top 1%
- Cannabis and Cannabinoid Research
- Toxicology top 2%
- Forensic Toxicology and Drug Analysis
Papers in
-
- Cannabis and Cannabinoid Research 3
- Co-authors
- Russell Noyes (3 shared papers)Arthur Canter (3 shared papers)David Avery (2 shared papers)D A Baram (1 shared paper)William R. Wilson (6 shared papers)James E. Krook (3 shared papers)A. Curtis Hass (1 shared paper)Robert F. Marschke (2 shared papers)
- Journals
- Clinical Pharmacology & Therapeutics (4 papers)Cancer (3 papers)The Journal of Clinical Pharmacology (2 papers)Radiology (1 paper)Comprehensive Psychiatry (1 paper)
- Partner nations
- United StatesMalaysiaCanada
In The Last Decade
S. Fred Brunk
19 papers receiving 873 citations
Peers
Comparison fields: 5 of 87
- Pharmacology 536
- Toxicology 91
- Anesthesiology and Pain Medicine 111
- Cellular and Molecular Neuroscience 222
- Pharmacology 65
Countries citing papers authored by S. Fred Brunk
This map shows the geographic impact of S. Fred Brunk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Fred Brunk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Fred Brunk more than expected).
Fields of papers citing papers by S. Fred Brunk
This network shows the impact of papers produced by S. Fred Brunk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Fred Brunk. The network helps show where S. Fred Brunk may publish in the future.
Co-authors
The 25 scholars most cited alongside S. Fred Brunk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1975 | 317 | |
| 2 | 1975 | 228 | |
| 3 | 1974 | 206 | |
| 4 | 1990 | 49 | |
| 5 | 1971 | 30 | |
| 6 | 1971 | 28 | |
| 7 | 1976 | 26 | |
| 8 | 1974 | 16 | |
| 9 | 1974 | 15 | |
| 10 | 1976 | 13 | |
| 11 | 1985 | 13 | |
| 12 | 1971 | 13 | |
| 13 | 1976 | 12 | |
| 14 | 1974 | 10 | |
| 15 | 1973 | 8 | |
| 16 | 1973 | 3 | |
| 17 | Randomized trial of adriamycin (ADR) versus adriamycin + dibromodulcitol (DBD) as second line chemotherapy in women with advanced breast cancer | 1982 | 2 |
| 18 | 2003 | 1 | |
| 19 | 1973 | 1 |
About S. Fred Brunk
S. Fred Brunk is a scholar working on Molecular Biology, Pharmacology, Pulmonary and Respiratory Medicine, Oncology and Physiology, having authored 19 papers that have together received 991 indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (3 papers), Chemotherapy-induced cardiotoxicity and mitigation (2 papers), Forensic Toxicology and Drug Analysis (2 papers), Cancer Treatment and Pharmacology (2 papers), Pain Mechanisms and Treatments (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Analytical Methods in Pharmaceuticals (2 papers) and Blood disorders and treatments (2 papers). The work is most often cited by research in Pharmacology (536 citations), Toxicology (91 citations), Anesthesiology and Pain Medicine (111 citations), Cellular and Molecular Neuroscience (222 citations) and Pharmacology (65 citations). S. Fred Brunk has collaborated with scholars based in United States, Malaysia and Canada. Frequent co-authors include Russell Noyes, Arthur Canter, David Avery, D A Baram, William R. Wilson, James E. Krook, A. Curtis Hass, Robert F. Marschke, Lloyd K. Everson and J A Mailliard. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Cancer, The Journal of Clinical Pharmacology, Radiology and Comprehensive Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.